Dr. David S Schrump, M.D.
Claim this profileStudies Malignant Pleural Mesothelioma
Studies Mesothelioma
1 reported clinical trial
1 drug studied
Area of expertise
1Malignant Pleural Mesothelioma
Stage II
Stage I
BAP1 positive
2Mesothelioma
Stage II
Stage I
BAP1 positive
Clinical Trials David S Schrump, M.D. is currently running
More about David S Schrump, M.D.
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments David S Schrump, M.D. has experience with
- Decitabine/Cedazuridine (INQOVI)
Breakdown of trials David S Schrump, M.D. has run
Malignant Pleural Mesothelioma
Mesothelioma
BAP1 Mutation
Malignancies
Malignant Mesothelioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David S Schrump, M.D. specialize in?
David S Schrump, M.D. focuses on Malignant Pleural Mesothelioma and Mesothelioma. In particular, much of their work with Malignant Pleural Mesothelioma has involved Stage II patients, or patients who are Stage I.
Is David S Schrump, M.D. currently recruiting for clinical trials?
Yes, David S Schrump, M.D. is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that David S Schrump, M.D. has studied deeply?
Yes, David S Schrump, M.D. has studied treatments such as Decitabine/Cedazuridine (INQOVI).
What is the best way to schedule an appointment with David S Schrump, M.D.?
Apply for one of the trials that David S Schrump, M.D. is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.